A Spanish research center offers a synthetic hydrogel for immunotherapy and 3D printing

Summary:

A Spanish biomedical research networking center has developed a novel 3D (bio)printable hydrogel. They have also created the method for producing it and its use in T-cell culture for immunotherapies (particularly in cancer). The biomedical center is looking to establish license, research cooperation, or joint venture agreements.

Reference: TOES20200713001

Country: Spain

Submitted: 18. 9. 2020

View Partnering Opportunity

Keywords

Technology: Pharmaceutics; Medical Technology / Biomedical Engineering; Pharmaceutical Products / Drugs; Medical Biomaterials; Biopolymers

Market: Cellular and Molecular Biology; Oncology; Pharmaceuticals/fine chemicals; Other chemicals and materials (not elsewhere classified)

NACE: Manufacture of basic pharmaceutical products; Other research and experimental development on natural sciences and engineering

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.